x
Loading
+ -

University of Basel

10 February 2017

Michael N. Hall awarded Cancer Research Prize

Prof. Dr. Michael N. Hall. (Image: University of Basel, Biozentrum)
Prof. Dr. Michael N. Hall. (Image: University of Basel, Biozentrum)

On February 8th, 2017, the American National Foundation for Cancer Research announced that Michael N. Hall, Professor of Biochemistry at the Biozentrum of the University of Basel, has been selected as the winner of the 2017 Szent-Györgyi Prize for Progress in Cancer Research. The award recognizes his groundbreaking discovery of the protein kinase TOR – target of rapamycin – and its role in cell growth control and carcinogenesis.

With the Szent-Györgyi Prize, the American National Foundation for Cancer Research honors Prof. Michael N. Hall at the Biozentrum, University of Basel, for his fundamental contributions to the understanding of critical life processes. The chair of the 2017 Prize Selection Committee, Prof. Mary-Claire King from the University of Washington, emphasizes that “Hall's work is a lovely example of how basic science – experimental studies of proteins in yeast – can lead to discoveries of clinical importance.” The prize will be presented at a festive ceremony on May 1st, 2017, at the National Press Club in Washington, D.C., USA.

“I am honored to have our cancer research recognized by the esteemed Szent-Györgyi Prize and to stand alongside the extraordinary scientists who have won it in previous years,” says prize winner Hall. “I hope our work continues to pave the way for new scientific discoveries that lead to effective cancer treatments.”

Thematic focal area
To top